Inhibrx Biosciences INBX
NASDAQ INBX
$93.38 -3.72 (-3.83%)
At close: Oct 23, 2026 · 4:00 PM EDT

Inhibrx Biosciences (INBX) Amortization of Deferred Charges (2023 - 2025)

Updated

Analysis

Inhibrx Biosciences (INBX) Amortization of Deferred Charges (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Inhibrx Biosciences 1.46 Bn 867.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 642,000.00
Sep 30, 2025 638,000.00
Jun 30, 2025 626,000.00
Mar 31, 2025 533,000.00
Jun 30, 2024 823,000.00
Mar 31, 2024 1.24 Mn
Dec 31, 2023 1.25 Mn
Sep 30, 2023 1.24 Mn
API Access

Inhibrx Biosciences Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=INBX&period=max&api_key=YOUR_API_KEY